Carbon-Ion Radiotherapy Triggers Ferroptosis via DHODH Suppr
2026-05-12
Wang and Cai (2025) demonstrate that carbon-ion radiotherapy (CIRT) suppresses gastric cancer progression by inducing ferroptosis and promoting M1 macrophage polarization through downregulation of DHODH. This mechanistic insight clarifies the superior antitumor efficacy of CIRT and highlights DHODH as a promising therapeutic target for improving radiotherapeutic outcomes.
Biotin-tyramide (A8011): Practical Guide for TSA Application
2026-05-11
Biotin-tyramide enables high-sensitivity signal amplification in immunohistochemistry and in situ hybridization workflows by leveraging HRP-mediated biotinylation. This reagent is not intended for diagnostic or medical use, and its application is limited to fixed cell and tissue assays that utilize enzyme-mediated amplification strategies.
Angiotensin I (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu): Mec
2026-05-11
Angiotensin I is a decapeptide central to renin-angiotensin system research and the immediate precursor of angiotensin II. Its role underpins cardiovascular disease models and antihypertensive drug screening. This article details its molecular mechanism, protocol parameters, and limitations with rigorous citation.
Dextran Sulfate Sodium Salt: Optimizing Mouse IBD Models
2026-05-10
Dextran sulfate sodium salt (MW 35000-45000) is the benchmark for robust, reproducible modeling of intestinal inflammation and epithelial repair in preclinical research. This guide delivers actionable workflows, troubleshooting strategies, and new insights from recent studies to accelerate ulcerative colitis research and drug discovery.
Refining In Vitro Drug Response: Insights from Schwartz’s Ca
2026-05-09
Schwartz’s dissertation advances in vitro anti-cancer drug evaluation by rigorously distinguishing between proliferative arrest and cell death, challenging the prevailing use of composite viability metrics. This nuanced approach clarifies how agents like Belinostat (PXD101) exert their effects, enabling more precise interpretation of experimental outcomes and improving translational relevance.
MDM1 Overexpression Boosts p53-Mediated Apoptosis in CRC The
2026-05-09
This study identifies MDM1 overexpression as a sensitizer for chemoradiotherapy in colorectal cancer by upregulating p53 expression and promoting apoptosis. The findings suggest that MDM1 could serve as a predictive biomarker and inform the design of p53 pathway-targeted therapies.
NADH Applications for Mitochondrial Electron Transport Chain
2026-05-08
NADH, the reduced nicotinamide adenine dinucleotide, is pivotal in energy metabolism and redox signaling, enabling advanced workflows in mitochondrial electron transport chain research, metabolic disease modeling, and photocatalytic cancer therapy. This article offers protocol-ready parameters, troubleshooting strategies, and translational insights, grounded in recent biosensor innovations and real-world assay optimization.
Sulfamonomethoxine Toxicity in Aquatic Species: Acute and Ch
2026-05-07
This study provides quantitative insights into the acute and chronic toxicity of sulfamonomethoxine (SMM), a sulfonamide antibiotic, across five aquatic organisms representing different trophic levels. Key findings highlight differential sensitivities, with microalgae being particularly susceptible, informing risk assessment and management strategies for aquaculture effluent.
Translational Precision: HRP Goat Anti-Mouse IgG (H+L) in GD
2026-05-07
This article explores the mechanistic and strategic role of the HRP Goat Anti-Mouse IgG (H+L) Antibody in advancing immunoassay fidelity for placental inflammation studies in gestational diabetes mellitus (GDM). By integrating mechanistic insights from recent miR-185-5p–CDC42–MAPK pathway discoveries, the discussion bridges foundational molecular findings with practical assay optimization. Emphasis is placed on robust detection, signal amplification, and workflow reproducibility, and the article positions APExBIO’s affinity-purified, horseradish peroxidase-conjugated secondary antibody as a pivotal tool for translational researchers seeking clinical impact.
COX-2 Pathway in Muscle Regeneration After Bothropic Venom I
2026-05-06
This study reveals a dual, time-dependent role for the cyclooxygenase-2 (COX-2) pathway in skeletal muscle regeneration following Bothrops asper venom-induced injury. Early COX-2 inhibition exacerbates ischemia, while later inhibition enhances proangiogenic signaling, offering nuanced insight for researchers designing muscle injury and vascular regeneration models.
APEX2 Regulates TERT Expression in Human Embryonic Stem Cell
2026-05-06
This study uncovers a previously unrecognized role for the DNA repair enzyme APEX2 in regulating TERT expression and telomerase activity in human embryonic stem cells and melanoma cells. The findings reveal a mechanistic link between genome stability, telomerase regulation, and cancer biology, opening avenues for targeted research on telomere maintenance and MAPK pathway modulation.
Clathrin-Mediated Entry of GCRV: Insights from Inhibitor Pro
2026-05-05
Wang et al. (2018) reveal that type III grass carp reovirus (GCRV104) enters host cells via clathrin-mediated endocytosis and requires endosomal acidification and dynamin function. Their systematic inhibitor analysis clarifies the cellular entry pathway and highlights distinctions from other viral entry mechanisms, informing future antiviral strategy development in aquatic virology.
Bestatin (Ubenimex): Precision Tools for Translational Prote
2026-05-05
This thought-leadership article explores Bestatin (Ubenimex) as a selective aminopeptidase inhibitor, blending mechanistic insight with strategic guidance for translational researchers. By connecting protease regulation to cell death pathways and multidrug resistance, and referencing recent advances in viral manipulation of necroptosis, the article delivers actionable advice for optimizing apoptosis and MDR assays. It further contextualizes Bestatin within the competitive landscape, highlights protocol parameters, and concludes with a visionary outlook on future translational impact.
Dextromethorphan Hydrobromide in Neuroprotection Research
2026-05-04
Dextromethorphan hydrobromide, a pure NMDA receptor antagonist, delivers reliable control of excitotoxicity and ion channel modulation in neuroprotection assays. This guide details rigorous workflow setup, protocol parameters, and troubleshooting to maximize reproducibility in both in vitro and in vivo neuroscience applications.
GDC-0941: Deep-Dive into PI3K Inhibition for Cancer Models
2026-05-04
Explore how GDC-0941, a selective PI3K inhibitor, enables advanced dissection of PI3K/Akt pathway inhibition and overcomes limitations in cancer research. This article offers unique mechanistic insights and protocol guidance not found in existing resources.
459 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page